Views of Cameroonian sex workers on a woman-controlled method of contraception and disease protection

International Journal of STD and AIDS

Volumn 9, Issue 11, 1998, Pages 695-699

  Visness, Cynthia M ^a,c   Ulin, Priscilla ^a   Pfannenschmidt, Susan ^a   Zekeng, Léopold ^b  

^a Women's Studies Division   (United States)

^b Unité de Lutte Contre le SIDA   (Cameroon)

^c FAMILY HEALTH INTERNATIONAL   (United States)

Author keywords

AIDS; Nonoxynol 9; Sexually transmitted diseases; Vaginal contraceptive film

Indexed keywords

NONOXINOL 9;

ARTICLE; CAMEROON; CLINICAL TRIAL; CONDOM; CONTRACEPTION; DRUG EFFICACY; DRUG FORMULATION; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVAGINAL DRUG ADMINISTRATION; NORMAL HUMAN; PREGNANCY; PRIORITY JOURNAL; PROSTITUTION; SEXUALLY TRANSMITTED DISEASE;

ACQUIRED IMMUNODEFICIENCY SYNDROME--PREVENTION AND CONTROL; AFRICA; AFRICA SOUTH OF THE SAHARA; BARRIER METHODS; BEHAVIOR; CAMEROON; COHORT ANALYSIS; CONDOM; CONTRACEPTION; CONTRACEPTIVE AGENTS; CONTRACEPTIVE METHODS; CONTRACEPTIVE USAGE; DEVELOPING COUNTRIES; DISEASES; FAMILY PLANNING; FRENCH SPEAKING AFRICA; HIV INFECTIONS--PREVENTION AND CONTROL; METHOD ACCEPTABILITY; MIDDLE AFRICA; NONOXYNOL-9; PROSTITUTES--WOMEN; RESEARCH METHODOLOGY; RESEARCH REPORT; SEX BEHAVIOR; SPERMICIDAL CONTRACEPTIVE AGENTS; VIRAL DISEASES;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CAMEROON; CONDOMS; FEMALE; HUMANS; NONOXYNOL; PATIENT SATISFACTION; PREGNANCY; PROSTITUTION; QUESTIONNAIRES; SEXUALLY TRANSMITTED DISEASES; SPERMATOCIDAL AGENTS;

EID: 0031787344     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462981921224     Document Type: Article

References (9)

1. Stein ZA. HIV pevention: the need for methods women can use. Am J Public Health 1990;80:460-2
2. Karim QA, Karim SS, Soldan K, Zondi M. Reducing the risk of HIV infection among the South African sex workers: socioeconomic and gender barriers. Am J Public Health 1995;85(11):1521-5
3. Niruthisard S, Roddy RE, Churivongse S. Use of nonoxynol-9 and reduction in rate of gonococcal and chlamydial cervical infections. Lancet 1992;339:1371-5
4. Roddy RE. Four Family Health International studies on barrier methods and sexually transmitted infections. In: Mauck CK, Cordero M, Gabelnick HL, Spieler JM, Rivera R, eds. Barrier Contraceptives: Current Status and Future Prospects. Proceedings of the 4th Contraceptive Research and Development Program International Workshop, 22-25 March 1993, Santo Domingo, Dominican Republic. New York: Wiley-Liss Publications, 1994:245-8
5. Weir SS, Feldblum PJ, Zekeng L, Roddy RE. The use of nonoxynol-9 for protection against cervical gonorrhea. Am J Public Health 1994;84(6):910-14
6. Malkovsky M, Newell A, Dalgleish AG. Inactivation of HIV by nonoxynol-9. Lancet 1988;i:645
7. Judson FN, Ehret JM, Bodin GF, Levin MJ, Reitmeijer AM. In vitro evaluations of condoms with and without nonoxynol-9 as physical and chemical barriers against Chlamydia trachomatis, herpes simplex virus 2 and human immunodeficiency virus. Sex Transm Dis 1989;61:51-6
8. Steiner M, Spruyt A, Joanis C, et al. Acceptability of spermicidal film and foaming tablets among women in three countries. Int Fam Plann Perspect 1995;21(3):104-7
9. Roddy RE, Zekeng L, Ryan KA, Tamoufé U, Weir SS, Wong EL. A controlled trial of nonoxynol-9 film to reduce male-to-female transmission of sexually transmitted diseases. N Engl J Med 1998;339(8):504-10